These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28771671)

  • 1. Assessment of the efficacy of a novel tailored vitamin K dosing regimen in lowering the International Normalised Ratio in over-anticoagulated patients: a randomised clinical trial.
    Kampouraki E; Avery PJ; Wynne H; Biss T; Hanley J; Talks K; Kamali F
    Br J Haematol; 2017 Sep; 178(5):800-809. PubMed ID: 28771671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appraisal of current vitamin K dosing algorithms for the reversal of over-anticoagulation with warfarin: the need for a more tailored dosing regimen.
    Sconce EA; Kamali F
    Eur J Haematol; 2006 Dec; 77(6):457-62. PubMed ID: 17042764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial.
    Crowther MA; Ageno W; Garcia D; Wang L; Witt DM; Clark NP; Blostein MD; Kahn SR; Vesely SK; Schulman S; Kovacs MJ; Rodger MA; Wells P; Anderson D; Ginsberg J; Selby R; Siragusa S; Silingardi M; Dowd MB; Kearon C
    Ann Intern Med; 2009 Mar; 150(5):293-300. PubMed ID: 19258557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of vitamin K in patients on anticoagulant therapy: a practical guide.
    Hanslik T; Prinseau J
    Am J Cardiovasc Drugs; 2004; 4(1):43-55. PubMed ID: 14967065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and safety of a management protocol to correct over-anticoagulation with oral vitamin K: a retrospective study of 1,043 cases.
    Denas G; Marzot F; Offelli P; Stendardo A; Cucchini U; Russo R; Nante G; Iliceto S; Pengo V
    J Thromb Thrombolysis; 2009 Apr; 27(3):340-7. PubMed ID: 18338109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial.
    Crowther MA; Julian J; McCarty D; Douketis J; Kovacs M; Biagoni L; Schnurr T; McGinnis J; Gent M; Hirsh J; Ginsberg J
    Lancet; 2000 Nov; 356(9241):1551-3. PubMed ID: 11075768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin K for improved anticoagulation control in patients receiving warfarin.
    Mahtani KR; Heneghan CJ; Nunan D; Roberts NW
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD009917. PubMed ID: 24832594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin K dosing to reverse warfarin based on INR, route of administration, and home warfarin dose in the acute/critical care setting.
    Tsu LV; Dienes JE; Dager WE
    Ann Pharmacother; 2012 Dec; 46(12):1617-26. PubMed ID: 23249867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10.
    Gunther KE; Conway G; Leibach L; Crowther MA
    Thromb Res; 2004; 113(3-4):205-9. PubMed ID: 15140584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Ansell J; Hirsh J; Poller L; Bussey H; Jacobson A; Hylek E
    Chest; 2004 Sep; 126(3 Suppl):204S-233S. PubMed ID: 15383473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
    Yasaka M; Sakata T; Naritomi H; Minematsu K
    Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose oral vitamin K therapy for the management of asymptomatic patients with elevated international normalized ratios: a brief review.
    Wilson SE; Watson HG; Crowther MA
    CMAJ; 2004 Mar; 170(5):821-4. PubMed ID: 14993179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study.
    Lubetsky A; Yonath H; Olchovsky D; Loebstein R; Halkin H; Ezra D
    Arch Intern Med; 2003 Nov; 163(20):2469-73. PubMed ID: 14609783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of asymptomatic over-anticoagulation by orally administered vitamin K.
    Baker P; Gleghorn A; Tripp T; Paddon K; Eagleton H; Keeling D
    Br J Haematol; 2006 May; 133(3):331-6. PubMed ID: 16643436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of pre-treatment INR level on the effect of intravenous low dose vitamin K in patients with excessive anticoagulation.
    Lubetsky A; Shasha Y; Olchovsky D; Loebstein R; Halkin H; Ezra D
    Thromb Haemost; 2003 Jul; 90(1):71-6. PubMed ID: 12876628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of overanticoagulation in very elderly hospitalized patients with an INR above 5.0: 24-hour INR response after vitamin K administration.
    Pautas E; Peyron I; Bouhadiba S; Golmard JL; Gouronnec A; Oboa N; Siguret V; Gouin-Thibault I
    Am J Med; 2011 Jun; 124(6):527-33. PubMed ID: 21605730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An oral vitamin K protocol to reverse over-anticoagulation in patients presenting with an International Normalised Ratio above 10.0.
    Denas G; Cucchini U; Iliceto S; Pengo V
    Thromb Haemost; 2009 Feb; 101(2):410-1. PubMed ID: 19190831
    [No Abstract]   [Full Text] [Related]  

  • 19. Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin.
    Woods K; Douketis JD; Kathirgamanathan K; Yi Q; Crowther MA
    J Thromb Thrombolysis; 2007 Oct; 24(2):93-7. PubMed ID: 17380255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin anticoagulation reversal: management of the asymptomatic and bleeding patient.
    Makris M; van Veen JJ; Maclean R
    J Thromb Thrombolysis; 2010 Feb; 29(2):171-81. PubMed ID: 19882303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.